HSA's Regulatory Information and Consumer Advisories on COVID-19

You can find the latest COVID-19 related guidances, advisories, updates and general information for dealers, healthcare professionals and consumers on this page.

General Updates

HSA’s Pandemic Special Access Route (PSAR) facilitates Singapore's access to critical novel vaccines, medicines and medical devices

How COVID-19 vaccine development and Pandemic Special Access Route (PSAR) interim authorisation have expedited access to vaccines

HSA grants interim authorisation for first COVID-19 vaccine in Singapore

HSA grants conditional approval of Remdesivir for treatment of COVID-19 infection

Collaborations with ICMRA (International Coalition of Medicines Regulatory Authorities)

Vaccine Information

Factsheets for healthcare professionals and vaccine recipients

For the Industry

Guidance on the expedited approval of COVID-19 diagnostic tests

Guidance on the import of surgical masks, hand sanitisers, respirators, thermometers and protective gear

Guidance on the supply of respiratory devices

Guidance on 3-D printing of essential medical devices and accessories for use in COVID-19 situation

Guidance on medical devices for decontamination of single use respirators during the COVID-19 situation

HSA CEO messages on facilitating development and access to COVID-19 related therapeutic products and devices

For Healthcare Professionals

Monitoring the safety profile of COVID-19 vaccines

Dear Healthcare Professional Letter - Interim authorisation of Pfizer-BioNTech COVID-19 vaccine (BNT162b2) for active immunisation to prevent COVID-19 disease in Singapore

Report vaccine adverse events

For Consumers

Advisory on herbal products claiming to prevent or treat COVID-19

Proper use and storage of alcohol-based hand sanitisers

Advisory on products claiming to prevent or treat COVID-19

Guide to masks and respirators

Last updated: 31 Dec 2018